Duolingo Inc vs Intuitive Surgical, Inc. — how do they compare? Duolingo Inc trades at $150.16 (market cap $7.08B), while Intuitive Surgical, Inc. trades at $424.11 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 20.7× Duolingo Inc's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Duolingo Inc for 137 Days and Intuitive Surgical, Inc. for 84 Days on average.
| DUOL | ISRG | |
|---|---|---|
Market Cap | $7.08B | $146.76B |
Volume | 729,171 | 2,529,814 |
Sector | Technology | Health |
52-Week High | $341.08 | $592.85 |
52-Week Low | $90.03 | $332.02 |
Typical Hold Time | 137 Days | 84 Days |
Enterprise Value | $5.85B | $141.54B |
Signals from Pluang's Aura AI — not financial advice
Duolingo (DUOL) trades at $150.50, down 0.8% on the day, as the stock consolidates near key resistance at $151. The company demonstrates strong fundamental momentum with revenue reaching $1.04 billion in 2025 and net income surging to $414 million, representing a robust 39.9% margin. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $0.66 exceeding the $0.604 forecast. Technical indicators show a bullish moving average alignment while RSI levels suggest potential near-term consolidation.
Duolingo presents a compelling growth story with accelerating profitability and strong user engagement, though valuation multiples remain elevated. Key risks include increased competition in edtech and insider selling activity. Analyst consensus leans cautious with a $140.63 price target below current levels, suggesting potential near-term headwinds despite the company's operational excellence.
Intuitive Surgical (ISRG) trades at $414.52, up 2.41% today, with strong bullish technical signals from moving averages. The company demonstrates robust fundamentals with revenue growth from $6.2B in 2022 to $10.1B in 2025 and net income margin expanding to 28.45%. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast.
ISRG maintains a dominant position in robotic surgery with expanding international growth, though valuation multiples remain elevated with a P/E of 47.64. Analyst consensus is strongly bullish with a $480.78 price target representing 16% upside potential. Key risks include competitive pressures and international market volatility, particularly in China.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →